Release of ciprofloxacin from poloxamer-graft-hyaluronic acid hydrogels in vitro

International Journal of Pharmaceutics

Volumn 260, Issue 1, 2003, Pages 83-91

  Cho, K Y ^a   Chung, T W ^a   Kim, B C ^a   Kim, M K ^b   Lee, J H ^b   Wee, W R ^b   Cho, C S ^a  

^a Seoul National University   (South Korea)

^b Seoul National University College of Medicine   (South Korea)

Author keywords

Hyaluronic acid; Mucoadhesive; Ophthalmic drug delivery; Poloxamer

Indexed keywords

1 (3 DIMETHYLAMINOPROPYL) 3 ETHYLCARBODIIMIDE; CIPROFLOXACIN; COPOLYMER; HYALURONIC ACID; POLOXAMER; SUCCINIMIDE DERIVATIVE;

ARTICLE; DRUG DELIVERY SYSTEM; DRUG RELEASE; GELATION; HYDROGEL; IN VITRO STUDY; INFRARED SPECTROSCOPY; PRIORITY JOURNAL; PROTON NUCLEAR MAGNETIC RESONANCE; VISCOSITY;

EID: 0038683264     PISSN: 03785173     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0378-5173(03)00259-X     Document Type: Article

References (25)

1. Balazs, E.A., Denlinger, J.L., 1989. Clinical uses of hyaluronan. In: Evered, D., Whelan, J. (Eds.), The Biology of Hyaluronan. Wiley, Chichester, pp. 265-280.
2. Chein, Y.W., Cabana, B.E., Mares, S.E., 1982. Ocular controlled release drug administration. In: Novel Drug Delivery Systems: Fundamentals, Development Concepts, Biomedical Assessments. In: Chein, Y.W. (Ed.), Drugs and the Pharmaceutical Sciences, vol. 14. Marcel Dekker Inc., New York and Basel, pp. 13-55.
3. Chung T.W., Yang J., Akaike T., Cho K.Y., Nah J.W., Kim S.I., Cho C.S. Preparation of alginate/galactosylated chitosan scaffold for hepatocyte attachment. Biomaterials. 23:2002;2827-2834.
4. Cohen S., Lobel E. A novel in situ-forming ophthalmic drug delivery system from alginates undergoing gelation in the eye. J. Control. Rel. 44:1997;201-208.
5. Desai S.D. In vitro evaluation of pluronic F127-based controlled-release ocular delivery systems for pilocarpine. J. Pharm. Sci. 87:1998;226-230.
6. Edsman K., Carlfors J., Petersson R. Rheological evaluation of poloxamer as an in situ gel for ophthalmic use. European J. Pharm. Sci. 6:1998;105-112.
7. Entwistle J., Hall C.L., Turley E.A. HA receptors: regulators of signalling to the cytoskeleton. J. Cell Biochem. 61:1996;569-577.
8. Gurny R. Preliminary study of prolonged acting drug delivery system for the treatment of glaucoma. Pharm. Acta Helv. 56:1981;130-132.
9. Gurny R., Boye T., Ibrahim H. Ocular therapy with nanoparticulate systems for controlled drug delivery. J. Control. Rel. 2:1985;353-361.
10. Hsiue G.H., Hsu S.H., Yang C.C., Lee S.H., Yang I.K. Preparation of controlled release ophthalmic drops, for glaucoma therapy using thermosensitive poly-N-isopropylacrylamide. Biomaterials. 23:2002;457-462.
11. Katakam M., Ravis W.R., Banga A.K. Controlled release of human growth hormone in rats following parenteral administration of poloxamer gels. J. Control. Rel. 49:1997;21-26.
12. Lin H.R., Sung K.C. Carbopol/pluronic phase change solutions for ophthalmic drug delivery. J. Control. Rel. 69:2000;379-388.
13. Middleton, D.L., Leung, S.S., Robinson, J.R., 1990. Bioadhesive Drug Delivery Systems. CRC Press, Boca Raton, FL, pp. 179-202.
14. Miller S.C., Donovan M.D. Effect of poloxamer 407 gel on the miotic activity of pilocarpine nitrate in rabbits. Int. J. Pharm. 12:1982;147-152.
15. Miyauchi S., Morita M., Kuramoto K., Horie K. Hyaluronan and chondroitin sulfate in rabbit tears. Cur. Eye Res. 15:1996;131-135.
16. Moghimi S.M., Hunter A.C. Poloxamers and poloxamines in nanoparticle engineering and experimental medicine. TIBTECH. 18:2000;412-420.
17. Patton T.F., Robinson J.R. Quantitative precorneal disposition of topically applied pilocarpine nitrate in rabbit eyes. J. Pharm. Sci. 65:1976;1295-1301.
18. Rozier A., Manuel C., Croove J., Plazonnet B. Gelrite: a novel, ion-activated, in situ gelling polymer for ophthalmic vehicles. Effect on bioavailability of timolol. Int. J. Pharm. 57:1989;163-168.
19. Saettone M.F., Monti D., Torracca M.T., Chetoni P. Mucoadhesive ophthalmic vehicles: evaluation of polymeric low-viscosity formulations. J. Ocular Pharm. 10:1994;83-92.
20. Sanzgirl Y.D., Maschi S., Crescenzi V., Callegaro L., Topp E.M., Stella V.J. Gellan-based systems for ophthalmic sustained delivery of methylprednisolone. J. Control. Rel. 26:1993;195-201.
21. Sechoy O., Tissie G., Sebastian C., Maurin F., Driot J.Y., Trinquand C. A new long acting ophthalmic formulation of carteolol containing alginic acid. Int. J. Pharm. 207:2000;109-116.
22. Sieg J.W., Robinson J.R. Vehicle effects on ocular drug bioavailability II: evaluation of pilocarpine. J. Pharm. Sci. 66:1977;1222-1228.
23. Spancake C.W., Mitra A.K., Kildsig D.O. Kinetics of aspirin hydrolysis in agueous solutions and gels of poloxamines (Tetronic 1508). Influence of microenvironment. Int. J. Pharm. 75:1991;231-239.
24. Vadnere M., Amidon G., Lindenbaum S., Haslam J.L. Thermodynamic studies on the gel-sol transition of some pluronic polyols. Int. J. Pharm. 22:1984;207-218.
25. Vercruysse K.P., Prestwich G.D. Hyaluronate derivatives in drug delivery. Crit. Rev. Ther. Carrier Syst. 15:1998;513-555.